NCT06945822View on ClinicalTrials.gov

Characterizing the Host Response to Leptospirosis for Better Diagnosis and Prognosis - NIHFI

NANot yet recruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

July 1, 2029

Study Completion Date

July 1, 2029

Conditions
Leptospirosis
Interventions
OTHER

Blood sample

"For febrile patients with confirmed (group 1) or refuted (group 2) diagnosis of leptospirosis:~\- At D0, D1, D3 and D15 a 20-ml blood sample~For healthy patients (group 3):~\- At D0 and D15: a 20-ml blood sample"

OTHER

Urine Sample

For all participants, a 5-ml urine sample at D0

Sponsors

Lead Sponsor

Institut Pasteur
All Listed Sponsors
collaborator

Centre Terrritorial Hospitalier Gaston Bourret

UNKNOWN

lead

Institut Pasteur

INDUSTRY

NCT06945822 - Characterizing the Host Response to Leptospirosis for Better Diagnosis and Prognosis - NIHFI | Biotech Hunter | Biotech Hunter